Cargando…

Optimizing the Management of High-Risk, Localized Prostate Cancer

Prostate cancer has a high prevalence and a rising incidence in many parts of the world. Although many screen-detected prostate cancers may be indolent, prostate cancer remains a major contributor to mortality in men. Therefore, the appropriate diagnosis and treatment of localized prostate cancer wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundi, Debasish, Jeong, Byong Chang, Lee, Seung Bae, Han, Misop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531632/ https://www.ncbi.nlm.nih.gov/pubmed/23301123 http://dx.doi.org/10.4111/kju.2012.53.12.815

Ejemplares similares

Very high risk localized prostate cancer: definition and outcomes
por: Sundi, Debasish, et al.
Publicado: (2013)

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Is there an optimal management for localized prostate cancer?
por: Singh, Jaspreet, et al.
Publicado: (2010)

Management of High-Risk Localized Prostate Cancer
por: Marciscano, Ariel E., et al.
Publicado: (2012)

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
por: Lee, Hye Won, et al.
Publicado: (2015)

What Is New in the Management of High-Risk Localized Prostate Cancer?
por: Wani, Mudassir, et al.
Publicado: (2023)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation
por: Daneshdoust, Danyal, et al.
Publicado: (2023)

Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy
por: Chapin, Brian F
Publicado: (2015)

Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels
por: Yang, Jin Bak, et al.
Publicado: (2010)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022)

Editorial for the Special Issue on High-Risk Localized and Locally Advanced Prostate Cancer
por: Izumi, Kouji
Publicado: (2023)

Advances in Localized Prostate Cancer Management
por: Samadi, David B., et al.
Publicado: (2018)

Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15)
por: Choi, Seo Hee, et al.
Publicado: (2021)

Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer
por: Xia, Leilei, et al.
Publicado: (2020)

Predictive Factors of Gleason Score Upgrading in Localized and Locally Advanced Prostate Cancer Diagnosed by Prostate Biopsy
por: Moon, Seung Jin, et al.
Publicado: (2010)

A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder
por: Truong, Hong, et al.
Publicado: (2013)

Episodic Hypertension With an Adrenal Mass: A Red Herring()
por: Neugarten, Carter J., et al.
Publicado: (2014)

Needle in a haystack: Robotic removal of a retroperitoneal wire
por: Yudovich, Max S., et al.
Publicado: (2020)

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era
por: Chen, Maxine M., et al.
Publicado: (2020)

HDR Brachytherapy in the Management of High-Risk Prostate Cancer
por: Masson, Susan, et al.
Publicado: (2012)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

Perspectives on the clinical management of localized prostate cancer
por: Nelson, Joel B
Publicado: (2014)

Short- and long-term outcomes of local excision with adjuvant radiotherapy in high-risk T1 rectal cancer patients
por: Al-Sawat, Abdullah, et al.
Publicado: (2022)

Role of robot-assisted radical prostatectomy in the management of high-risk prostate cancer
por: Sood, Akshay, et al.
Publicado: (2014)

Focal Therapy in the Management of Prostate Cancer: An Emerging Approach for Localized Prostate Cancer
por: Nomura, Takeo, et al.
Publicado: (2012)

Pre- and Post-Operative Nomograms to Predict Recurrence-Free Probability in Korean Men with Clinically Localized Prostate Cancer
por: Kang, Minyong, et al.
Publicado: (2014)

Rare Renal Incidentaloma in Pregnancy: An Unusual Primitive Neuroectodermal Tumor Presentation
por: Torga, Gonzalo, et al.
Publicado: (2015)

Treatment of Localized and Locally Advanced, High-Risk Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries
por: Khauli, Raja, et al.
Publicado: (2021)

Primary Total Prostate Cryoablation for Localized High-Risk Prostate Cancer: 10-Year Outcomes and Nomograms
por: Chen, Chung-Hsin, et al.
Publicado: (2023)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

A structured framework for optimizing high-intensity focused ultrasound ablative treatment in localized prostate cancer
por: Castellani, Daniele, et al.
Publicado: (2019)

Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for Metastases
por: Brown, Gordon, et al.
Publicado: (2022)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Poor Glycemic Control of Diabetes Mellitus Is Associated with Higher Risk of Prostate Cancer Detection in a Biopsy Population
por: Park, Juhyun, et al.
Publicado: (2014)

Future Prospects in the Diagnosis and Management of Localized Prostate Cancer
por: Tefekli, Ahmet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vbeutrtn278csr0b4k13q7jqen